ONE STEP CLOSER
DEAD

Serial Number

90581862

Owner

CVS PHARMACY, INC.

Attorney

Erich G. Rhynhart

Filing Date

Mar 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ONE STEP CLOSER Trademark

Serial Number: 90581862

ONE STEP CLOSER is a trademark filed by CVS PHARMACY, INC. on March 16, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

CVS PHARMACY, INC. (1,090 trademarks)

WOONSOCKET, RI 02895

Entity Type: 03

Trademark Details

Filing Date

March 16, 2021

Registration Date

Not Registered

Published for Opposition

May 24, 2022

Goods & Services

education services, namely, conducting instructional programs, seminars, workshops and training in the fields of health and wellness; personal coaching services in the field of health; Providing educational programs related to COVID-19 and other infectious diseases

retail store and online retail pharmacy services in the field of prescription drugs, healthcare, wellness, general consumer merchandise and medical products; promoting public awareness of the need for education in the fields of health and wellness; Promoting public awareness of COVID-19 and other infectious diseases; Promoting awareness of actions to address COVID-19 and other infectious diseases by means of public advocacy and public information campaigns; Promoting public awareness of the importance of vaccination in connection with COVID-19 and other infectious diseases; Developing and delivering testing strategies and vaccination solutions for COVID-19 and other infectious diseases; Promoting awareness of protocols and safety measures to prevent the spread of Covid-19 and other infectious diseases; Promoting awareness of vaccination to prevent the spread of COVID-19 and other infectious diseases

personal lifestyle performance assessments based on principles of emotional intelligence, by means of performance tracking, reward and incentive programs; Providing workplace safety information to employers, employees, and individuals in connection with COVID-19 and other infectious diseases; Providing a website featuring public safety information related to COVID-19 and other infectious diseases

providing health care services, namely, wellness and disease management programs; personal health assessments, namely, personal assessments of health risk, physical fitness assessment for medical purposes, nutrition and lifestyle wellness; providing smoking cessation treatment and weight loss program services; providing medication counseling services and providing information related thereto; managed health care services, namely, health and wellness counseling services; health care, namely, disease care management services; providing health care information in the field of health and wellness, and disease management; medical care services; nursing services; medical care services, namely, providing personalized and customized health and wellness assessment, health care, disease management, medical treatment and wellness plans and programs; medical care services, namely, evaluating and monitoring a patient's condition; providing medical information, namely, providing information on healthcare, health and wellness programs, medication counseling, and medical symptoms, conditions, procedures, and services; providing online telemedicine services; medical clinics featuring non-emergency medical diagnostic services in convenient locations; COVID-19 and infectious disease testing, screening, vaccination and reporting services; Medical diagnostic testing of bodily fluids for use in COVID-19 and other infectious disease detection; Medical diagnostic testing, vaccination, and screening for COVID-19 and other infectious diseases; Providing medical diagnostic testing, vaccination, screening, and reporting services in connection with COVID-19 and other infectious diseases; Providing medical information to employers, employees, patients and individuals in connection with COVID-19 and other infectious diseases; Providing healthcare, medical, wellness, and vaccination services related to COVID-19 and other infectious diseases; Providing educational medical information in the field of COVID-19 and other infectious diseases; Providing a website featuring medical information related to COVID-19 and other infectious diseases

providing a website featuring technology that enables health plan participants to access and download personalized information about health care services; providing an interactive website featuring technology that enables users to access and search for information regarding health care, health care coverage and benefits, health claims status, health fund transactions, health care providers and facilities, preferred drug list, estimated health care costs and print member id cards; Diagnostic testing for others for research purposes of bodily fluids for use in COVID-19 and other infectious disease detection; Diagnostic testing for others for research purposes for COVID-19 and other infectious diseases; Providing Diagnostic testing for others for research purposes in connection with COVID-19 and other infectious diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 8, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 13, 2024 EXRA
SOU EXTENSION 4 GRANTED
Jun 5, 2024 EX4G
SOU EXTENSION 4 FILED
Jun 5, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2023 EXRA
SOU EXTENSION 3 GRANTED
Dec 20, 2023 EX3G
SOU EXTENSION 3 FILED
Dec 20, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Dec 20, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2023 EXRA
SOU EXTENSION 2 GRANTED
Jul 10, 2023 EX2G
SOU EXTENSION 2 FILED
Jul 10, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 10, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 14, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 12, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 12, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 12, 2022 EEXT
ASSIGNED TO EXAMINER
Nov 16, 2022 DOCK
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 19, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 24, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 24, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 4, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 18, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Oct 21, 2021 GPRN
PRIORITY ACTION E-MAILED
Oct 21, 2021 GPRA
PRIORITY ACTION WRITTEN
Oct 21, 2021 CPRA
ASSIGNED TO EXAMINER
Oct 18, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2021 NWOS
NEW APPLICATION ENTERED
Mar 19, 2021 NWAP